The Effect of Bright Light Treatment on Rest-Activity Rhythms in People with Dementia: A 24-Week Cluster Randomized Controlled Trial

被引:5
|
作者
Kolberg, Eirin [1 ]
Pallesen, Stale [2 ,3 ,4 ]
Hjetland, Gunnhild Johnsen [1 ,5 ]
Nordhus, Inger Hilde [1 ,6 ]
Flo-Groeneboom, Elisabeth [1 ]
机构
[1] Univ Bergen UiB, Fac Psychol, Dept Clin Psychol, N-5009 Bergen, Norway
[2] Univ Bergen UiB, Fac Psychol, Dept Psychosocial Sci, N-5015 Bergen, Norway
[3] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, N-5021 Bergen, Norway
[4] North West Univ, Optentia, Vaal Triangle Campus, ZA-1911 Vanderbijlpark, South Africa
[5] City Dept Hlth & Care, N-5007 Bergen, Norway
[6] Univ Oslo UiO, Fac Med, Dept Behav Med, N-0372 Oslo, Norway
来源
CLOCKS & SLEEP | 2021年 / 3卷 / 03期
关键词
dementia; nursing homes; bright light therapy; rest-activity rhythms; actigraphy; circadian rhythms; clinical trial; CIRCADIAN ACTIVITY RHYTHMS; NURSING-HOME RESIDENTS; MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; INSTITUTIONALIZED PATIENTS; MELATONIN SECRETION; SLEEP; EXPOSURE; DISTURBANCES; INTERVENTION;
D O I
10.3390/clockssleep3030032
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Bright light treatment is an effective way to influence circadian rhythms in healthy adults, but previous research with dementia patients has yielded mixed results. The present study presents a primary outcome of the DEM.LIGHT trial, a 24-week randomized controlled trial conducted at nursing homes in Bergen, Norway, investigating the effects of a bright light intervention. The intervention consisted of ceiling-mounted LED panels providing varying illuminance and correlated color temperature throughout the day, with a peak of 1000 lx, 6000 K between 10 a.m. and 3 p.m. Activity was recorded using actigraphs at baseline and after 8, 16, and 24 weeks. Non-parametric indicators and extended cosine models were used to investigate rest-activity rhythms, and outcomes were analyzed with multi-level regression models. Sixty-one patients with severe dementia (median MMSE = 4) were included. After 16 weeks, the acrophase was advanced from baseline in the intervention group compared to the control group (B = -1.02, 95%; CI = -2.00, -0.05). There was no significant difference between the groups on any other rest-activity measures. When comparing parametric and non-parametric indicators of rest-activity rhythms, 25 out of 35 comparisons were significantly correlated. The present results indicate that ambient bright light treatment did not improve rest-activity rhythms for people with dementia.
引用
收藏
页码:449 / 464
页数:16
相关论文
共 50 条
  • [21] METHYLPHENIDATE FOR ADHD IN ADULTS WITH SUBSTANCE DEPENDENCE A 24-WEEK RANDOMIZED PLACEBO-CONTROLLED TRIAL
    Konstenius, M.
    Jayaram-Lindstrom, N.
    Guterstam, J.
    Philips, B.
    Beck, O.
    Franck, J.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [22] A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer's disease
    Thal, LJ
    Ferguson, JM
    Mintzer, J
    Raskin, A
    Targum, SD
    NEUROLOGY, 1999, 52 (06) : 1146 - 1152
  • [23] A 24-week, randomized, controlled trial of adjunctive topiramate versus sibutramine in the treatment of weight gain in patients with bipolar disorder
    McElroy, SL
    Altshuler, LL
    Frye, MA
    Suppes, T
    Mintz, J
    Kupka, R
    Nolen, W
    Leverich, GS
    Denicoff, KD
    Post, RM
    Keck, PE
    BIPOLAR DISORDERS, 2005, 7 : 76 - 76
  • [24] Efficacy and tolerability of donepezil in vascular dementia -: Positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial
    Black, S
    Román, GC
    Geldmacher, DS
    Salloway, S
    Hecker, J
    Burns, A
    Perdomo, C
    Kumar, D
    Pratt, R
    STROKE, 2003, 34 (10) : 2323 - 2330
  • [25] MS disease activity in RESTORE A randomized 24-week natalizumab treatment interruption study
    Fox, Robert J.
    Cree, Bruce A. C.
    De Seze, Jerome
    Gold, Ralf
    Hartung, Hans-Peter
    Jeffery, Douglas
    Kappos, Ludwig
    Kaufman, Michael
    Montalban, Xavier
    Weinstock-Guttman, Bianca
    Anderson, Britt
    Natarajan, Amy
    Ticho, Barry
    Duda, Petra
    NEUROLOGY, 2014, 82 (17) : 1491 - 1498
  • [26] Effects of Rehabilitation Program on Quality of Life, Sleep, Rest-Activity Rhythms, Anxiety, and Depression of Patients With Esophageal Cancer A Pilot Randomized Controlled Trial
    Chen, Hui-Mei
    Lin, Yi-Yun
    Wu, Yu-Chung
    Huang, Chien-Sheng
    Hsu, Po-Kuei
    Chien, Ling-, I
    Lin, Yu-Jung
    Huang, Hsiu-Li
    CANCER NURSING, 2022, 45 (02) : E582 - E593
  • [27] Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease
    Dowling, Glenna A.
    Burr, Robert L.
    Van Someren, Eus J. W.
    Hubbard, Erin M.
    Luxenberg, Jay S.
    Mastick, Judy
    Cooper, Bruce A.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (02) : 239 - 246
  • [28] Gingivitis efficacy of a 0.454% w/w stannous fluoride dentifrice: a 24-week randomized controlled trial
    Parkinson, C. R.
    Milleman, K. R.
    Milleman, J. L.
    BMC ORAL HEALTH, 2020, 20 (01)
  • [29] INTRAMUSCULAR DEPOT METHYLPREDNISOLONE INDUCTION OF CHRYSOTHERAPY IN RHEUMATOID-ARTHRITIS - A 24-WEEK RANDOMIZED CONTROLLED TRIAL
    CORKILL, MM
    KIRKHAM, BW
    CHIKANZA, IC
    GIBSON, T
    PANAYI, GS
    BRITISH JOURNAL OF RHEUMATOLOGY, 1990, 29 (04): : 274 - 279
  • [30] Gingivitis efficacy of a 0.454% w/w stannous fluoride dentifrice: a 24-week randomized controlled trial
    C. R. Parkinson
    K. R. Milleman
    J. L. Milleman
    BMC Oral Health, 20